Table: Sapporo Clinical Lab -6-MTH group results
Nov 11 (Reuters)-
Sapporo Clinical Laboratory Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2016 Sep 30, 2015 Mar 31, 2017
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 8.43 8.60 17.69
(-1.9 pct) (+3.6 pct) (+0.9 pct)
Operating 350 mln 501 mln 697 mln
(-30.1 pct) (+32.5 pct) (-28.4 pct)
Recurring 370 mln 511 mln 727 mln
(-27.6 pct) (+29.8 pct) (-27.3 pct)
Net 239 mln 320 mln 476 mln
(-25.2 pct) (+36.3 pct) (-19.4 pct)
EPS 68.84 yen 92.04 yen 136.85 yen
Ann Div 11.00 yen 11.00 yen
-Q2 div NIL NIL
-Q4 div 11.00 yen 11.00 yen
NOTE - Sapporo Clinical Laboratory Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T
((Tokyo Headline News Desk +813 6441 1812))
Recent news on Sapporo Clinical Laboratory
See all newsTable: Sapporo Clinical Lab - 9-MTH group results
Table: Sapporo Clinical Lab - 6-MTH group results
Brief: Sapporo Clinical Laboratory Inc - To Retire Treasury Shares Worth 26% Of Outstanding Stock On Feb 17
Table: Sapporo Clinical Lab -Q1 group results
Table: Sapporo Clinical Lab -2024/25 parent results